TCL Archive Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer February 25, 2011
TCL Archive FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated November 28, 1975